257 essays 1,087 funds measured independent · not paid by any fund or issuer we cover

Fund · First Trust Small Cap Growth AlphaDEX Fund · measured from SEC filings

FYC holdings

FYC reports 263 holdings and behaves like 214.2 equally weighted ones, computed from its SEC Form N-PORT filing for 2026-07-31. The fact sheet publishes the first number; this page computes the second, and traces it across 27 quarters of filings.

Measured concentration

as of 2026-07-31

Read this figure with the following in mind

1.0% of net assets is securities-lending cash collateral, excluded from the figure; counted as filed the fund would read 209.2

The figure below is what the filing says, published unchanged. What it may not do is sit beside a plain long-only fund and be read as the same quantity. How comparability is decided.

263 Positions reported
214.2 Effective holdings
1.2× Concentration multiple
7.5% Top ten weight

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 98.97% at a quoted market price (level 1), 8 issuer countries.

What stands out

as of 2026-07-31

FYC's largest investment is Maxlinear Inc at 1.81% of net assets. Applied Optoelectronics Inc and Anaptysbio Inc follow; the three together are 3.76%. Ten companies are 7.5% of the fund; the other 253 share the rest. Among the 721 equity funds measured here, FYC behaves like 214.2 holdings against a median of 42.4 — 5.0 times the median. Across 27 quarterly filings FYC has held roughly steady since 2019-10-31 (211.2 then, 198 now). Between the 2026-01-31 and 2026-04-30 filings 111 positions were added and 111 dropped; 53.6% of the weight moved.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Every filing since 2019

27

Between 2019-10-31 and 2026-04-30, FYC went from behaving like 211.2 equally weighted positions to 198 — 6% fewer, while its top ten went from 7.27% to 9.31% of net assets. Read across the funds on the concentration-over-time table.

PeriodHoldingsEffective Top 10Largest
2026-04-30 263 198 9.31% 1.81%
2026-01-31 263 204.7 8.25% 0.91%
2025-10-31 263 200.5 8.9% 1.36%
2025-07-31 263 210 7.75% 0.88%
2025-04-30 263 208.7 7.69% 0.96%
2025-01-31 263 209.8 7.66% 0.86%
2024-10-31 263 209.9 7.4% 0.86%
2024-07-31 263 212.1 7.26% 0.79%
Earlier filings (19 more, back to 2019-10-31)
PeriodHoldingsEffectiveTop 10Largest
2024-04-30 263 209.5 7.85% 1.09%
2024-01-31 262 210.5 7.4% 0.91%
2023-10-31 262 210.8 7.3% 0.77%
2023-07-31 262 211.7 7.29% 0.93%
2023-04-28 262 212 7.17% 0.77%
2023-01-31 262 213.4 7.37% 0.86%
2022-10-31 262 208.5 7.81% 0.83%
2022-07-29 262 213.2 7.32% 0.78%
2022-04-29 262 205.2 7.86% 0.94%
2022-01-31 262 210.8 7.75% 0.88%
2021-10-29 262 207.5 7.77% 0.98%
2021-07-30 262 211.4 7.23% 0.77%
2021-04-30 262 211.2 7.5% 0.79%
2021-01-29 262 203.4 8.53% 1.11%
2020-10-30 262 211.5 7.66% 0.84%
2020-07-31 262 206.1 8.07% 1.25%
2020-04-30 262 213.9 7.37% 0.82%
2020-01-31 261 210.2 7.37% 0.89%
2019-10-31 262 211.2 7.27% 0.79%

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

As filed, collateral included

1.04% collateral

FYC's filing lists 264 positions including 1.04% of net assets in securities-lending cash collateral. Counted as filed the fund reads 209.2 effective holdings with a top ten of 7.84%; on its own investments — the figure above — it reads 214.2 with a top ten of 7.5%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

Largest positions, as filed

as of 2026-04-30

The 15 largest of 263 positions in FYC's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: FYC.csv.gz.

#PositionWeightCumulative
1MAXLINEAR INC1.81%1.8%
2APPLIED OPTOELECTRONICS INC1.08%2.9%
3ANAPTYSBIO INC0.86%3.8%
4INHIBRX BIOSCIENCES INC0.86%4.6%
5CUSTOM TRUCK ONE SOURCE INC0.83%5.4%
6MYR GROUP INC0.80%6.2%
7KAISER ALUMINUM CORP0.79%7.0%
8GARRETT MOTION INC0.78%7.8%
9BEL FUSE INC0.77%8.6%
10ADEIA INC0.74%9.3%
11SOLARIS ENERGY INFRASTRUCTURE INC0.73%10.0%
12RELAY THERAPEUTICS INC0.72%10.8%
13EZCORP INC0.72%11.5%
14CENTURI HOLDINGS INC0.72%12.2%
15AMPRIUS TECHNOLOGIES INC0.69%12.9%

By country of issuer

as of 2026-04-30

Share of FYC's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

CountryShare
United States 96.77%
Cayman Islands° 1.32%
Ireland° 0.67%
Bahamas 0.48%
British Virgin Islands° 0.40%
Jersey° 0.15%
Bermuda° 0.11%
Netherlands° 0.10%

Returns the fund reported

2019-08 – 2026-04

Monthly total returns from Item B.5 of FYC's own filings, 81 months on record. Not computed here and not from a price feed.

62.9%Last twelve months filed
144%Whole series, compounded
18.2%Best month
-22.4%Worst month

Cross-checked against a series computed separately from prices: median difference 0.12 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: FYC.json · all funds.

Who borrows FYC's shares

2026-07-31

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $13m was out to 12 borrowers. The largest, MORGAN STANLEY & CO LLC, held 26.7% of it.

BorrowerOn loanShare of the loan
MORGAN STANLEY & CO LLC $3m 26.7%
BARCLAYS CAPITAL INC. $3m 21.4%
BofA Securities, Inc. $2m 14.6%
Scotia Capital (USA) Inc $1m 8.0%
UBS AG $979,418 7.5%

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter FYC has filed, with each borrower: FYC.json · all funds.

Since the previous filing

2026-01-31 → 2026-04-30

263 positions became 263: 111 added (43.5% of the fund at the later date), 111 dropped (39.3% at the earlier date). Half the sum of all weight changes, a turnover proxy: 53.6%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of FYC compared this way, as a feed: changes.xml · all funds: filings received.

Largest increases2026-01-312026-04-30Largest decreases2026-01-312026-04-30
REMITLY GLOBAL INC0.12%0.62% VIRIDIAN THERAPEUTICS INC0.66%0.15%
IRIDIUM COMMUNICATIONS INC0.14%0.63% CADRE HOLDINGS INC0.61%0.11%
APPLIED OPTOELECTRONICS INC0.62%1.08% ACM RESEARCH INC0.91%0.43%
AMERICAN SUPERCONDUCTOR CORP0.13%0.52% PROGYNY INC0.58%0.12%
ADEIA INC0.38%0.74% NEWAMSTERDAM PHARMA COMPANY NV0.55%0.10%
CINEMARK HOLDINGS INC0.12%0.46% WILLDAN GROUP INC0.75%0.33%

New: MAXLINEAR INC (1.81%), ANAPTYSBIO INC (0.86%), INHIBRX BIOSCIENCES INC (0.86%), KAISER ALUMINUM CORP (0.79%), RELAY THERAPEUTICS INC (0.72%), EZCORP INC (0.72%). Gone: Vicor Corp (0.89%), Mirum Pharmaceuticals Inc (0.81%), Eos Energy Enterprises Inc (0.79%), Planet Labs PBC (0.78%), Lemonade Inc (0.75%), Tutor Perini Corp (0.73%).

Asset categories and pricing

as of 2026-07-31
Asset category (as filed)Share of investments
equity EC98.92%
repurchase agreement RA1.03%
short-term investment STIV0.05%

99.0% of FYC is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

Neighbours by effective holdings, equity funds

10

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of FYC (214.2). Same filings, same arithmetic. Position in this list says nothing about which fund is better.

FundReportsBehaves likeTop tenAs of
INTF iShares International Equity Factor ETF 498 208.5 12.83% 2026-07-31
IJJ iShares S&P Mid-Cap 400 Value ETF 303 208.8 10.09% 2026-06-30
MDYV State Street(R) SPDR(R) S & P 400(TM) Mid Cap Value ETF 302 209.2 10.07% 2026-06-30
IVOV Vanguard S&P Mid-Cap 400 Value Index Fund 304 210.1 10.2% 2026-05-31
GSID Goldman Sachs MarketBeta International Equity ETF 894 213.3 13.31% 2026-05-31
VEU Vanguard FTSE All-World Ex-US Index Fund 3,890 216 14.39% 2026-07-31
VYMI Vanguard International High Dividend Yield Index Fund 1,580 217.9 13.89% 2026-07-31
SMIN iShares MSCI India Small-Cap ETF 475 220.2 13.3% 2026-05-31
NUSC Nuveen ESG Small-Cap ETF 405 222.4 10.19% 2026-07-31
SPDW State Street(R) SPDR(R) Portfolio Developed World ex-US ETF 2,444 227.8 14.04% 2026-06-30

Essays that examine FYC

0

Mentions are detected across the full text of every article, so an appearance may be a passing comparison rather than the subject. Nothing here is a recommendation to buy or sell — see the disclaimer.